Why this high-flying ASX 200 healthcare stock just crashed 11%

Why this high-flying ASX 200 healthcare stock just crashed 11%

Motley Fool

Published

Neuren Pharmaceuticals just dropped its 1Q FY24 report on DAYBUE sales.

Full Article